First Author | Jain C | Year | 2023 |
Journal | Exp Hematol | Volume | 125-126 |
Pages | 25-36.e1 | PubMed ID | 37562670 |
Mgi Jnum | J:340025 | Mgi Id | MGI:7524976 |
Doi | 10.1016/j.exphem.2023.08.001 | Citation | Jain C, et al. (2023) Myeloid Hif2alpha is not essential to maintain systemic iron homeostasis. Exp Hematol |
abstractText | Dietary consumption serves as the primary source of iron uptake, and erythropoiesis acts as a major regulator of systemic iron demand. In addition to intestinal iron absorption, macrophages play a crucial role in recycling iron from senescent red blood cells. The kidneys are responsible for the production of erythropoietin (Epo), which stimulates erythropoiesis, whereas the liver plays a central role in producing the iron-regulatory hormone hepcidin. The transcriptional regulator hypoxia-inducible factor (HIF)2alpha has a central role in the regulation of Epo, hepcidin, and intestinal iron absorption and therefore plays a crucial role in coordinating the tissue crosstalk to maintain systemic iron demands. However, the precise involvement of Hif2alpha in macrophages in terms of iron homeostasis remains uncertain. Our study demonstrates that deleting Hif2alpha in macrophages does not disrupt the expression of iron transporters or basal erythropoiesis. Mice lacking Hif2alpha in myeloid cells exhibited no discernible differences in hemodynamic parameters, including hemoglobin concentrations and erythrocyte count, when compared with littermate controls. This similarity was observed under conditions of both dietary iron deficiency and acute erythropoietic demand. Notably, we observed a significant increase in the expression of iron transporters in the duodenum during iron deficiency, indicating heightened iron absorption. Therefore, our findings suggest that the disruption of Hif2alpha in myeloid cells does not significantly impact systemic iron homeostasis under normal physiologic conditions. However, its disruption induces adaptive physiologic changes in response to elevated iron demand, potentially serving as a mechanism to sustain increased erythropoietic demand. |